BioSpace News Archive

The Government of Canada is aware that the United Kingdom is investigating a new SARS-CoV-2 variant, which has been identified in cases in areas where there is also a high incidence of COVID-19.

As the resurgence of COVID-19 activity continues in Canada , we are tracking a range of epidemiological indicators to monitor where the disease is most active, where it is spreading and how it is impacting the health of Canadians and public health, laboratory and healthcare capacity. The following is the latest summary on national numbers

UPDATE: December 24, 2020 – Additional lots of GUM Paroex being recalled because this product may be contaminated with the bacteria Burkholderia lata.

Vaccines destined for the Canadian North will have travelled more than 10,000 kilometers to reach vaccination centres

MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended October 31, 2020. Profit and Loss Highlights Revenue: The Company recorded revenues in Q1 FY2021 of $1,602,823 compared to $89,132 in Q1 FY2020. The increase in revenue was due to the Company’s revenues generated from sales of the REVEALCOVID-19 TM Total Antibody Test and associated products and services. Gross Profit: The Company rec